Therefore, the relative low expression of AMPK and mTOR pathway is a distinct feature of NALM-6/HDR, which might be another key point to understand the mechanisms of GC resistance in ALL [6], and NALM-6/HDR may provide a novel model that represents a subtype of GC-resistant B-ALL cells. This evidence concerns the gene MTOR and acute lymphoblastic leukemia.